Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spenser Biomedical Technology is a South Korean medical technology company specializing in advanced digital solutions for dental and maxillofacial surgery. The company's flagship product is the BOS system, a virtual surgical planning (VSP) software platform that utilizes 3D visualization and simulation to enhance the precision of complex orthognathic procedures. In addition to its software offerings, Spenser manufactures the Bluefin Implant system and specialized dental barrier membranes designed for periodontal tissue regeneration. By integrating 3D printing technology with digital planning, the company provides patient-specific surgical guides and anatomical models that improve surgical efficiency and clinical outcomes. Spenser's mission is focused on delivering safe, predictable, and economical healthcare solutions through technological innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spenser Biomedical Technology.